Overview

Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study

Status:
Recruiting
Trial end date:
2022-02-22
Target enrollment:
Participant gender:
Summary
25 patients with primary low-risk basal cell carcinoma treated with calcium electroporation
Phase:
Phase 3
Details
Lead Sponsor:
Bispebjerg Hospital
Collaborator:
Mirai Medical, Ireland
Treatments:
Calcium